ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Research Companies Join With Nonprofits

by Michael McCoy
July 18, 2011 | APPEARED IN VOLUME 89, ISSUE 29

The Innovative Vector Control Consortium has signed an agreement with the contract research firm Scynexis to find compounds suitable for development into new active ingredients for insecticides. Scynexis will screen its chemical library for activity against adult mosquitoes and create methods for screening other libraries from organizations around the world. Meanwhile, the Michael J. Fox Foundation for Parkinson’s Research has signed a pact with BioFocus related to Parkinson’s disease treatments. BioFocus will perform fragment-based screening and assay development and will run hit-finding programs.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment